Altana Report issue

Contributed to NME For profit Phase 4
Founded: Wesel Germany (1977)
Status: Acquired by Nycomed (1999) (2006) → now Takeda (2011)

Organization Overview

First Clinical Trial
2005
NCT00163306
First Marketed Drug
1977
chloramphenicol (chloromycetin)
First NDA Approval
2004
terconazole (terazol)
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ALTANA | Altana Pharma AG, D-78467 Konstanz, Germany, info.clintrials@altanapharma.com | Altana Pharma, D-78467 Konstanz, Germany

Active Ingredients

Marketed Drugs (7)

chloramphenicol (chloromycetin) (1968)

ciclesonide (alvesco) (2008 NDA)

desoximetasone (topicort) (1998)

erythromycin (ilosone) (1991)

promethazine hydrochloride (phenergan) (1978)

terconazole (terazol) (2004 NDA)

urea (1982)

Drugs in Phase 4 Trials (1)

pantoprazole (protonix) (2 trials)

Indications

Approved Indications


 

Asthma

Candidiasis, Vulvovaginal

Rhinitis, Allergic, Perennial

Rhinitis, Allergic, Seasonal

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophagitis, Peptic (Phase 4)

Gastroesophageal Reflux (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1